A new publication involving difelikefalin was released on August 3, 2026. The article, titled "The neuroimmune architecture of uremic pruritus: mechanisms and therapeutic targeting," appeared in the Journal of Nephrology.
The publication is listed under PubMed ID 42544762. It addresses mechanisms and therapeutic targeting related to uremic pruritus, a condition for which difelikefalin is an approved treatment.
No specific findings, results, or conclusions from the publication were included in the available event data. This brief reports only that the publication exists and identifies its title, journal, and date.
Readers interested in further detail should consult the original publication directly. For general background on difelikefalin, see the compound overview.